Ads
related to: pharmaceuticals
Search results
Insider Sale: EVP & CFO Colleen Tupper Sells Shares of Collegium Pharmaceutical Inc (COLL)
GuruFocus.com via Yahoo Finance· 21 hours agoOn May 28, 2024, Colleen Tupper, Executive Vice President and Chief Financial Officer of Collegium ...
There's a way to see what Big Pharma is paying your doctor
Quartz· 5 hours agoWhen doctors take money or gifts from pharmaceutical companies those are required by law to be...
What Happened After I Stopped Taking a Weight-Loss Drug
The Wall Street Journal· 3 hours agoFour months ago, I wrote about losing 40 pounds on Mounjaro and wondered how I would do without the...
Cns Pharmaceuticals Inc [CNSP] Shares Fall Approximately
Knox Daily· 21 hours agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cns Pharmaceuticals Inc shares valued at $50,000 were purchased by Climaco ...
Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Docetaxel Injection, USP Due to...
The Marysville Advocate· 2 days ago(PRNewsfoto/Sagent Pharmaceuticals, Inc.) (PRNewsfoto/Sagent Pharmaceuticals, Inc.)
How to Look Up the Money Your Doctor Is Getting From Big Pharma
Gizmodo via Yahoo Finance· 9 hours agoWhen doctors take money or gifts from pharmaceutical companies those are required by law to be...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 7 hours agoVanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that ownership of the U.S. New Drug Application and Investigational New Drug Applications for PONVORY® (ponesimod ...
Recursion Pharmaceuticals Inc [RXRX] Shares Fall
Knox Daily· 21 hours agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Recursion Pharmaceuticals Inc shares valued at ...
Insider Sale: EVP & CFO Colleen Tupper Sells Shares of Collegium Pharmaceutical Inc (COLL) By...
Investing.com· 1 day agoOn May 28, 2024, Colleen Tupper, Executive Vice President and Chief Financial Officer of Collegium ...
FDA approves higher dose of Catalyst's LEMS drug By Investing.com
Investing.com· 10 hours agoCatalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a commercial-stage biopharmaceutical company,...